Advocating for patients is core to our mission. One way we do this is by building long-standing relationships with patient advocates and patient advocacy organizations that share our values. Together, we work to raise awareness of patient needs, advance patient-centered drug development and increase access to medicines and other forms of treatment in support of patient health and well-being for people living with psychiatric and neurological disorders.
We actively seek input from patients and advocates early in our drug development process to help identify unmet patient needs and inform our research. These engagement efforts help us design clinical trials and programs with specific patient outcomes in mind. We continue to consult with patients through application for regulatory approval for our medicines and beyond, so that patient perspectives continue to inform our work.
The challenges presented by addiction, serious mental illness, narcolepsy and other neurological disorders can impact every aspect of life. Across our endeavors, we are purposeful about staying connected to the reality of living with these diseases. Much of our charitable work focuses on helping to address the comprehensive needs of those impacted by serious diseases in our therapeutic areas of focus.
We are committed to amplifying authentic stories of people who live with – or those who care for people who live with – complex psychiatric and neurological disorders. This includes some of our own employees. Our hope is to help combat the widespread stigma associated with serious mental illness, substance use disorders and sleep disorders, and build greater compassion and understanding for people living with these conditions.
.